Prescription only. For use under the supervision of a qualified healthcare provider.

BLACK BOX WARNING – Risk of Thyroid C-Cell Tumors

• Do not use Wegovy® if you:
  • Have a personal or family history of medullary thyroid carcinoma (MTC).
  • Have multiple endocrine neoplasia syndrome type 2 (MEN 2).
  • Have ever had thyroid cancer.
• In animal studies, GLP-1 receptor agonists caused thyroid tumors, including cancer. It is not known if this occurs in humans.
• Call your healthcare provider immediately if you notice a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.

Before Using Wegovy®

Tell your healthcare provider about your full medical history, including if you have:

• Kidney, liver, or pancreas problems
• Severe gastrointestinal disease
• A history of diabetic retinopathy
• Depression, suicidal thoughts, or behavior changes
  

Discuss all prescription and non-prescription medications, vitamins, and herbal supplements you take, especially:

• Insulin or insulin secretagogues (e.g., sulfonylureas)
• Thyroid hormone medication
• Medications with a narrow therapeutic range (e.g., warfarin)

Pregnancy, Breastfeeding & Contraception

• Do not use if you are pregnant, planning to become pregnant, or breastfeeding.
• Stop Wegovy® at least 2 months before trying to conceive.
• Use effective contraception while on treatment.
• Wegovy® may cause fetal harm.

Alcohol

Avoid alcohol while taking Wegovy®.

Serious Warnings – Call Your Doctor Immediately If You Experience:

• Thyroid C-cell tumor symptoms (see Black Box Warning)
• Pancreatitis: severe abdominal or back pain that does not go away, with or without vomiting
• Gallbladder disease: pain in the upper right stomach, fever, yellowing skin/eyes, nausea/vomiting
• Kidney problems/failure: reduced urination, swelling, fatigue (especially if dehydrated from nausea, vomiting, or diarrhea)
• Hepatitis or elevated liver enzymes: yellowing skin/eyes, dark urine
• Diabetic retinopathy changes: sudden vision changes
• Serious allergic reaction: swelling of face/lips/tongue/throat, difficulty breathing or swallowing, rash, itching, fainting, dizziness, or rapid heartbeat
• Severe gastrointestinal issues
• Hypoglycemia (especially if also taking insulin/sulfonylureas): dizziness, confusion, sweating, rapid heartbeat, shakiness, headache
• Increased heart rate
• Worsening depression or suicidal thoughts
  

If any of these occur, stop Wegovy® and seek immediate medical attention.

Common Side Effects

Some people experience no side effects. The most common include:

• Nausea, vomiting, diarrhea, constipation, abdominal pain, bloating, belching, flatulence
• Headache, dizziness, fatigue
• Indigestion, upset stomach, acid reflux
• Nasopharyngitis (common cold)
• Back pain
• Altered taste
• Decreased appetite
• Injection site reactions
• Gastroenteritis
• Increased lipase or amylase
  

Most side effects improve as your body adjusts. Contact your provider if symptoms persist.

Drug Interactions

• Wegovy® may delay stomach emptying, which can affect absorption of oral medications.
• Dose adjustments may be required for insulin, sulfonylureas, thyroid hormone, and medications with a narrow therapeutic index.
• Monitor closely if on warfarin or other blood thinners.

Other Safety Notes

• Stay hydrated to reduce risk of dehydration-related kidney issues.
• Never share your Wegovy® pen with anyone, even if the needle is changed.

Emergency Information

• In case of a medical emergency, call 911 or go to the nearest emergency room.
• To report side effects, contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.